Clinical Trials Update: What to Know in Myelofibrosis Care
Replay Coming Soon
Discussion Details
Join Dr. Naveen Pemmaraju from MD Anderson Cancer Center in a discussion on current myelofibrosis treatments and promising developments in clinical trials. Listen in as myelofibrosis patient advocate Ruth Fein Revell makes sure important topics such as anemia and stem cell transplants are covered.
Register now to get an email when the event replay is ready. Discover what brings Dr. Pemmaraju hope in what he calls the “golden era for research” when it comes to myelofibrosis.
Key Topics:
- Current Standard of Care
- Switching JAK Inhibitors
- Clinical Trials: Combination Therapy
- Trials Beyond JAK Inhibitors
- Effective Anemia Treatment
- Is Transplant an Option?
- Hope for Living Longer
Special thanks again to GSK and AbbVie for their support of our independent patient education content. The Patient Story retains full editorial control.
Myelofibrosis Patient Stories
We hope you’ve registered for our program. In the meantime, our patient stories provide valuable insights from others living with myelofibrosis.
Holly S.
Symptoms: Severe fatigue, throbbing pain in left calf, significant weight loss, itching and rashes, bruising, and shortness of breath
Treatment: Oral chemotherapy: hydroxyurea, Immunotherapy injections: peginterferon
